Doctor profile · Federal record

Dr. Rachel Neumoyer, CRNP

Nurse Practitioner · Nurse Practitioner · Havre de Grace, MD

  • NPI 1801191770
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 16 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
930 Revolution St
Havre de Grace, MD 210783718
(443) 351-3376

Credentials & registration

NPPES · NUCC
NPI registered
January 2011 — 15 yrs on file
Profile last updated
February 2, 2021
Year of graduation
2010 — 16 yrs since
Specialty taxonomy
363L00000X — NUCC code
State licenses (2)
Maryland #R154451 · Delaware #LG-0000539
Medicaid
MD #210178500

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1801191770. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,886
Distinct HCPCS
10
Medicare allowed
$273,342
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,847 312 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 895 667 $82
17000 Destruction of precancer skin growth, 1 growth 584 423 $47
11102 Biopsy of related skin growth, first growth 291 252 $84
17110 Destruction of skin growth, 1-14 growths 272 239 $104
96910 Therapy procedure using ultraviolet radiation with tar or petroleum jelly application 218 20 $111
99212 Established patient office or other outpatient visit, 10-19 minutes 193 170 $51
99214 Established patient office or other outpatient visit, 30-39 minutes 168 132 $116
11103 Biopsy of related skin growth, each additional growth 89 64 $47
99203 New patient office or other outpatient visit, 30-44 minutes 65 65 $102

In context: peer comparison

Among 1 peers in Havre de Grace Nurse Practitioner, average services per provider: 232. This provider delivers 21× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,854
Transactions
75
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 13 $380.00
Lilly USA, LLC 3 $241.86
Dermavant Sciences, INC. 17 $210.04
Janssen Biotech, INC. 11 $198.27
Abbvie INC. 4 $105.73
Sun Pharmaceutical Industries INC. 4 $101.50
Genzyme Corporation 2 $85.20
E.R. Squibb & Sons, L.L.C. 4 $77.07
Ucb, INC. 2 $69.95
Arcutis Biotherapeutics, INC. 4 $66.35
Amgen INC. 2 $61.62
Regeneron Healthcare Solutions, INC. 2 $57.27
Sandoz INC. 2 $49.92
Ortho Dermatologics, A Division of Bausch Health US, LLC 3 $47.79
Pfizer INC. 2 $44.03

By nature of payment

Food and Beverage
$1,754
Education
$100

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
653
Patients
375
Total drug cost
$86,410
Drug Type Claims Patients Total cost
Ketoconazole Generic 122 74 $2,532
Triamcinolone Acetonide Generic 93 63 $599
Doxycycline Hyclate Generic 67 23 $2,008
Hydrocortisone Generic 65 48 $453
Mupirocin Generic 65 44 $592
Clobetasol Propionate Generic 54 29 $1,961
Fluorouracil Generic 34 28 $2,687
Ammonium Lactate Generic 24 16 $575
Ciclopirox Generic 21 0 $1,196
Clindamycin Phosphate Generic 21 14 $861

Frequently asked questions

Auto-generated from federal data
What is Dr. Rachel Neumoyer's medical specialty?
Dr. Rachel Neumoyer practices Nurse Practitioner in Havre de Grace, MD.
Where does Dr. Rachel Neumoyer practice?
Dr. Rachel Neumoyer practices at 930 Revolution St, Havre de Grace, MD 210783718. Office phone: 4433513376.
What is Dr. Rachel Neumoyer's NPI?
Dr. Rachel Neumoyer's National Provider Identifier (NPI) is 1801191770, issued by NPPES.
Does Dr. Rachel Neumoyer accept Medicare assignment?
Yes. Dr. Rachel Neumoyer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Neumoyer commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.